|
|
|
|
|
|
|
|
open access
20 May 2016
With recent changes in the management of cancer, longer life expectancy, and a heightened awareness of supportive care issues, an updated analysis to evaluate the current prevalence and perception of fatigue in current oncology practice was needed. We aimed to determine whether HCP awareness of the substantial impact of fatigue on the lives of patients with cancer has led to a decrease in its prevalence. We also aimed to compare perspectives on fatigue to similar perspectives on pain in cancer.
Patient-reported most recently diagnosed cancer (number [%]) included breast (212 [39]), lung (74 [14]), colon (47 [9]), ovarian (44 [8]), prostate (30 [6]), uterine (16 [3]), liver (15 [3]), brain (13 [2]), bladder (12 [2]), and rectal (12 [2]).
Purpose
In 1997, Vogelzang et al.
reported that 61 % of patients with cancer indicated fatigue impacted
daily life more than pain, and only 37 % of oncologists shared this
perception. We provide an update to this study, which can help
prioritize symptom assessment and management in the clinic. Study aims
were to determine and compare perceptions of patients with cancer and
health care providers (HCPs) of the impact of fatigue and pain.
Conclusions
This study shows the importance
of assessing symptoms by direct patient report during chemotherapy
treatment. HCPs continue to underestimate the prevalence and importance
of fatigue and pain for patients with cancer, a finding that may alter
the management of treatment-related symptoms and may influence the
development of patient symptom management plans.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.